(Q36079809)

12 August 2017

p53 immunohistochemistry as an independent prognostic factor for superficial transitional cell carcinoma of the bladder (English)

1 reference

transitional cell carcinoma

12 August 2017

1 reference

1 reference

Serth J

1

1 reference

12 August 2017

Kuczyk MA

2

1 reference

12 August 2017

Bokemeyer C

3

1 reference

12 August 2017

Hervatin C

4

1 reference

12 August 2017

Nafe R

5

1 reference

12 August 2017

Tan HK

6

1 reference

12 August 2017

Jonas U

7

1 reference

12 August 2017

language of work or name

English

0 references

publication date

1 January 1995

1 reference

British Journal of Cancer

12 August 2017

1 reference

12 August 2017

71

1 reference

12 August 2017

201-205

1 reference

12 August 2017

1

1 reference

https://scigraph.springernature.com/pub.10.1038/bjc.1995.41

12 August 2017

0 references

cites work

Clinical implications of the p53 tumor-suppressor gene

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2033435

Prognosis in carcinoma of the urinary bladder based upon tissue blood group abh and Thomsen-Friedenreich antigen status and karyotype of the initial tumor.

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2033435

Activating mutations for transformation by p53 produce a gene product that forms an hsc70-p53 complex with an altered half-life

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2033435

Cell proliferation kinetics in human solid tumors: relation to probability of metastatic dissemination and long-term survival

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2033435

The p53 proto-oncogene can act as a suppressor of transformation

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2033435

Superficial bladder cancer. Risk of recurrence and potential role for interferon therapy

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2033435

Human p53 is phosphorylated by p60-cdc2 and cyclin B-cdc2

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2033435

Ki-67 and other proliferation markers useful for immunohistological diagnostic and prognostic evaluations in human malignancies

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2033435

Identification of p53 gene mutations in bladder cancers and urine samples

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2033435

Expression of mutant p53, c-erbB-2 and the epidermal growth factor receptor in transitional cell carcinoma of the human urinary bladder

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2033435

Altered Expression of Retinoblastoma Protein and Known Prognostic Variables in Locally Advanced Bladder Cancer

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2033435

Prognostic significance of p53 overexpression in gastric and colorectal carcinoma

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2033435

p53 expression in human breast cancer

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2033435

Molecular genetics of colorectal carcinoma

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2033435

Clonal origin of bladder cancer

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2033435

Cell proliferation of transitional cell bladder tumours determined by PCNA/cyclin immunostaining and its prognostic value

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2033435

Accumulation of p53 Tumor Suppressor Gene Protein: An Independent Marker of Prognosis in Breast Cancers

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2033435

Molecular markers for the diagnosis and prognosis of lung cancer

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2033435

T antigen is bound to a host protein in SY40-transformed cells

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2033435

Cellular immortalization by a cDNA clone encoding the transformation-associated phosphoprotein p53

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2033435

Monoclonal antibody analysis of the proliferating cell nuclear antigen (PCNA). Structural conservation and the detection of a nucleolar form

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2033435

Cell proliferation of transitional cell bladder cancer determined by PCNA/cyclin immunostaining. A histopathological description

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2033435

Accumulation of p53 protein correlates with a poor prognosis in human lung cancer

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2033435

Distinct pattern of p53 mutations in bladder cancer: relationship to tobacco usage

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2033435

Isolation of human-p53-specific monoclonal antibodies and their use in the studies of human p53 expression.

23 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2033435

Prognostic factors in non-infiltrating carcinoma of the bladder: a preliminary report

23 September 2018

1 reference

12 December 2020

Mutant p53, EGF receptor and c-erbB-2 expression in human breast cancer

1 reference

12 December 2020

Molecular biology of bladder cancer

1 reference

12 December 2020

Small Subgroup of Aggressive, Highly Proliferative Prostatic Carcinomas Defined by p53 Accumulation

1 reference

12 December 2020

Nuclear overexpression of p53 protein in transitional cell bladder carcinoma: a marker for disease progression

1 reference

12 December 2020

Urothelial dysplasia and carcinoma in situ of the bladder

1 reference

12 December 2020

Identifiers

DOI

10.1038/BJC.1995.41

1 reference

12 August 2017

1 reference

12 August 2017

1 reference